{"abstract":"This final rule adopts, without change, an interim final rule with request for comments published in the Federal Register on October 6, 2020, placing the substance remimazolam, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, in schedule IV of the Controlled Substances Act. With the issuance of this final rule, DEA maintains remimazolam, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, in schedule IV of the Controlled Substances Act.","action":"Final rule.","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2021/06/02/2021-11512.html","cfr_references":[{"chapter":null,"citation_url":null,"part":"1308","title":21}],"citation":"86 FR 29506","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":"The effective date of this rulemaking is July 2, 2021.","disposition_notes":null,"docket_ids":["Docket No. DEA-658"],"dockets":[],"document_number":"2021-11512","effective_on":"2021-07-02","end_page":29509,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2021/06/02/2021-11512.xml","html_url":"https://www.federalregister.gov/documents/2021/06/02/2021-11512/schedules-of-controlled-substances-placement-of-remimazolam-in-schedule-iv","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2021-11512?publication_date=2021-06-02","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2021-06-02/2021-11512/mods.xml","not_received_for_publication":null,"page_length":4,"page_views":{"count":683,"last_updated":"2026-11-22 14:15:04 -0500"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2021-06-02/pdf/2021-11512.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2021-11512.pdf?1622551531","publication_date":"2021-06-02","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2021/06/02/2021-11512.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[{"title":"FINAL SIGNED ASH Response to DEA Remimazolam_04162020","document_id":"DEA-2020-0028-0003"},{"title":"Remimazolam DEA 658 8-factor","document_id":"DEA-2020-0028-0002"}],"comments_count":0,"agency_id":"DEA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=DEA-2020-0028","supporting_documents_count":2,"docket_id":"DEA-2020-0028","document_id":"DEA-2020-0028-0007","regulation_id_number":null,"title":"Schedules of Controlled Substances: Placement of Remimazolam in Schedule IV","checked_regulationsdotgov_at":"2021-08-19T03:30:13Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":29506,"subtype":null,"title":"Schedules of Controlled Substances: Placement of Remimazolam in Schedule IV","toc_doc":"Placement of Remimazolam in Schedule IV","toc_subject":"Schedules of Controlled Substances:\n","topics":["Administrative practice and procedure","Drug traffic control","Reporting and recordkeeping requirements"],"type":"Rule","volume":86}